Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2021

Open Access 01-12-2021 | Levothyroxine | Letter to the Editor

Letter to “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment”

Authors: Sadettin Öztürk, Ersin Akarsu

Published in: Endocrine | Issue 3/2021

Login to get access

Excerpt

We read the manuscript entitled “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment” with great interest and pleasure [1]. We thought some points should be clarified so we decided to explain the test result discrepancies. İn the article to determine the absorbtion rate in patients with high levels of thyroid-stimulating hormone (TSH) despite receiving adequate doses of levothyroxine; …
Literature
1.
IlginYildirim Simsir, UtkuErdem Soyaltin, AhmetGokhan Ozgen, Levothyroxine absorption test results in patients with TSH elevation resistant to treatment. Endocrine 64, 118–121 (2019)CrossRef
2.
GraceE.Ching Sun et al. The clinical utility of free thyroxine in oral levothyroxine absorption testing. Endocr. Pract. 20, 925–929 (2014)CrossRef
3.
KennethB. Ain et al. Pseudomalabsorption of levothyroxine. JAMA 266, 2118–2120 (1991)CrossRef
Metadata
Title
Letter to “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment”
Authors
Sadettin Öztürk
Ersin Akarsu
Publication date
01-12-2021
Publisher
Springer US
Keyword
Levothyroxine
Published in
Endocrine / Issue 3/2021
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02808-9

Other articles of this Issue 3/2021

Endocrine 3/2021 Go to the issue

Original Article

Distress, anxiety, depression and unmet needs in thyroid cancer survivors: a longitudinal study

Letter to the Editor

Graves’ disease following SARS-CoV-2 vaccination

Meta- Analysis

Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials

Original Article

Bone and body composition analyses by DXA in adults with GH deficiency: effects of long-term replacement therapy

Original Article

The relationship between lipotoxicity and risk of extrathyroidal extension in papillary thyroid microcarcinoma

Original Article

Association of decreased sperm motility and increased seminal plasma IGF-I, IGF-II, IGFBP-2, and PSA levels in infertile men

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits